Drug intelligence / Profile preview

half-normal saline

Development stage
Unknown
Lead developer
Sunnybrook Health Sciences Centre
Modality
Small Molecules
Administration
Intracardiac
01

Overview

Half-normal saline (0.45% sodium chloride) is a hypotonic saline solution utilized as an irrigant during radiofrequency (RF) catheter ablation for the treatment of typical cavotricuspid isthmus-dependent atrial flutter. In this procedural context, the solution is delivered through open-irrigated ablation catheters to the target cardiac tissue. The therapeutic rationale is based on the solution's lower ionic concentration compared to standard normal saline (0.9% NaCl), which reduces the electrical conductivity of the medium surrounding the catheter tip. This reduction in conductivity minimizes the dispersion of RF energy into the circulating blood pool and focuses the energy at the catheter-tissue interface. This biophysical modulation facilitates the creation of deeper and more transmural ablation lesions, which aims to reduce the time required to achieve bidirectional conduction block and improve long-term procedural success rates. Sunnybrook Health Sciences Centre has led multicenter clinical investigations (e.g., NCT04001530) to verify its superiority over normal saline in this indication.

Brand names
HAFNOR
Other names
0.45% sodium chloride0.45% NaClhalf-strength saline0.45% Sodium Chloride Injection

Beyond the preview

Go deeper on half-normal saline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on half-normal saline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call